Drug Patent Expirations for Nov 9, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

VIOXX (rofecoxib)
Merck
Patent number:6,063,811
Expiration Date:Nov 6, 2017

QUTENZA (capsaicin)
Acorda
Patent number:6,239,180
Expiration Date:Nov 6, 2017

PREZISTA (darunavir ethanolate)
Janssen Prods
Patent number:RE 43,596
Expiration Date:Nov 9, 2017

PREZCOBIX (cobicistat; darunavir ethanolate)
Janssen Prods
Patent number:RE 43,596
Expiration Date:Nov 9, 2017

AGENERASE (amprenavir)
Glaxosmithkline
Patent number:6,730,679
Expiration Date:Nov 11, 2017

ORBACTIV (oritavancin diphosphate)
The Medicines Co
Patent number:5,998,581
Expiration Date:Nov 12, 2017

INVEGA TRINZA (paliperidone palmitate)
Janssen Pharms
Patent number:6,077,843
Expiration Date:Nov 12, 2017

INVEGA SUSTENNA (paliperidone palmitate)
Janssen Pharms
Patent number:6,077,843
Expiration Date:Nov 12, 2017

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial


Leave a Reply

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: